About Cerus:
Cerus aims to be the global leader and trusted partner of blood centers and hospitals whose technology, services, and commitment are the lifeblood of safe and accessible blood for patients around the world.
Overarching Objective: Develop an understanding of how to assess product opportunities and develop go to market global strategies for novel medical device products in the field of transfusion medicine. In parallel, work with Investor Relations on a variety of topics to develop an understanding of NASDAQ public company IR efforts.
Goals for 6 week summer program:
Develop Investor Relations Messaging
Assessing INTERCEPT RBC U.S. red blood cell transfusion market opportunity
Expanding Wall Street Coverage
Identifying investment banks that have capabilities and the bandwidth to potentially add Cerus to their coverage
Valuation Assessment
Develop regression model - plotting the valuation of CERS and its peers
EV/Sales vs. Sales growth
Can we add a third parameter? How to include “cash runway” on impact on valuation? Positive cash flow = infinite runway.
Organizational / record keeping
Help catalogue historical IR files (presentations, press releases, presentations) in Box
Hourly rate: $18/hr
Lifelancer
10Folders
Ensono
Patrique Mercier Recruitment
KMC Solutions